Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
Previous studies have demonstrated that exhaled nitric oxide can be useful to monitor the efficacy of anti-inflammatory treatment as well as to predict a risk of asthma relapse in asthmatic patients.
The aim of the present study is to evaluate the time course of exhaled nitric oxide in mild asthmatic patients, stopping regular treatment with inhaled corticosteroids, if it is possible, in relationship with symptoms and lung function.
|Study Design:||Observational Model: Case-Only
Time Perspective: Cross-Sectional
|Official Title:||Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients Stopping Anti-inflammatory Treatment|
|Study Start Date:||January 2007|
|Study Completion Date:||January 2010|
All patients were evaluated with pulmonary lung function, exhaled nitric oxide and peak expiratory flow (PEF) and fill in a personal diary for the first two weeks when patients are in treatment; the same evaluation will be made for other four weeks without treatment.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01113853
|Pediatric Department University of Verona|
|Verona, Italy, 37100|
|Principal Investigator:||Giorgio L Piacentini, MD||Universita di Verona|